Company | Page 12 of 71 | SpiritIndia.com

Exercise :: New fitness guidelines clarify how much exercise is really enough

Most American adults don’t exercise enough, but updated national guidelines for physical fitness allow for flexibility and will make it easier to determine how much is enough to maintain good health, according to Health Fitness Corporation (HFC) (OTC Bulletin Board: HFIT), a national leader in worksite health management.

Weight Loss :: Confidence recalls METABOSLIM Apple Cider Vinegar brand dietary supplement

Confidence Inc. of Port Washington, NY, is recalling one lot of METABOSLIM Apple Cider Vinegar brand dietary supplement, lot number 3001006, EXP. 102009 and UPC CODE: 92483 00102 because it contains the undeclared drug ingredient sibutramine.

Health Insurance :: Mayo Clinic and Medica Expand Health Insurance Relationship

Mayo Clinic in Rochester, has entered into a multiyear arrangement that expands its relationship with Medica, a Minneapolis-based health insurance company that serves more than 1.3 million members in the Upper Midwest.

Head and Neck Cancer :: A new radiation therapy treatment developed for head and neck cancer patients

Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). These results were obtained in a Phase I/II study at the Helsinki University Hospital, Finland.

Medicine :: Shire supports Canada’s Access to Medicines Regime

Shire BioChem Inc. announced that it is pleased to support Canada?s Access to Medicines Regime to enable a Canadian company (Apotex) to manufacture in Canada a generic fixed dose triple combination antiretroviral medicine that contains a drug (3TC?) over which Shire BioChem Inc. holds patent rights in Canada.

Listeria :: Ocean King recalls Ready-To-Eat seafood dips because of Listeria risk

Ocean King Enterprises Inc. of Philadelphia, PA is recalling Ready-to-Eat Seafood Dips, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Diabetes :: No more needles for people with type 2 diabetes

Daily injections could be a thing of the past for people with diabetes thanks to an innovative new product supported by the Australian government.

Health :: TAS Innovation To Help Manage Chronic Disease

An innovative Hobart company has developed a system for hospitals and clinics which will prove invaluable in the management of chronic diseases.

Sinusitis :: Accentia issues update on blinded results in phase 3 of SinuNase for chronic sinusitis

Based on an interim blinded analysis of the first group of the more than 80 patients who have now completed the trial at 16 weeks, the study has shown improvement in polyposis by endoscopy in about 50 percent of patients (N=43) and improvement in sinus inflammation by CT scan in approximately 50 percent of patients (N=23). Moreover, 50 percent of patients with objective evidence of improvement have achieved the primary endpoint of complete resolution of cardinal symptoms.

Flu :: New target for anti-flu drug development

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.